Aldosterone, Renin, and Diabetes Mellitus in African Americans: The Jackson Heart Study.
暂无分享,去创建一个
A. Correa | M. Sims | R. Casanova | A. Bertoni | H. Yeh | R. Kalyani | S. Golden | G. Wand | J. Echouffo-Tcheugui | Wen‐Chih Wu | Joshua J. Joseph | V. Effoe | A. Correa
[1] G. Adler,et al. Mineralocorticoid Receptor Blockade Reverses Obesity-Related Changes in Expression of Adiponectin, Peroxisome Proliferator-Activated Receptor-&ggr;, and Proinflammatory Adipokines , 2008, Circulation.
[2] G. Adler,et al. The Renin Angiotensin Aldosterone System and Insulin Resistance in Humans , 2013, Current Hypertension Reports.
[3] R. Touyz,et al. Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways: Implications in Diabetes Mellitus–Associated Obesity and Vascular Dysfunction , 2012, Hypertension.
[4] J. M. Luther. Effects of aldosterone on insulin sensitivity and secretion , 2014, Steroids.
[5] B. Egan,et al. Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans. , 1999, Prostaglandins, leukotrienes, and essential fatty acids.
[6] M. Drazner,et al. Left Ventricular Hypertrophy Is More Prevalent in Blacks Than Whites in the General Population: The Dallas Heart Study , 2005, Hypertension.
[7] L. Sechi,et al. Aldosterone and the Heart: Still an Unresolved Issue? , 2014, Front. Endocrinol..
[8] 熊谷 英太. Plasma aldosterone levels and development of insulin resistance : prospective study in a general population , 2012 .
[9] Daniel W. Jones,et al. Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study. , 2005, Ethnicity & disease.
[10] P. Wilson,et al. Association of Adiponectin With Left Ventricular Mass in Blacks: The Jackson Heart Study , 2011, Circulation. Heart failure.
[11] M. Moța,et al. Type 2 diabetes mellitus and hypertension , 2016 .
[12] F. Beuschlein,et al. Aldosterone excess impairs first phase insulin secretion in primary aldosteronism. , 2013, The Journal of clinical endocrinology and metabolism.
[13] J. Sowers,et al. Type 2 diabetes mellitus and hypertension: an update. , 2014, Endocrinology and metabolism clinics of North America.
[14] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[15] D. Mozaffarian,et al. Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond , 2010, Circulation.
[16] D. Jacobs,et al. Plasma Aldosterone Levels and Development of Insulin Resistance: Prospective Study in a General Population , 2011, Hypertension.
[17] M. Laakso,et al. Effect of valsartan on the incidence of diabetes and cardiovascular events. , 2010, The New England journal of medicine.
[18] M. Sinno,et al. Do angiotensin converting enzyme inhibitors or angiotensin receptor blockers prevent diabetes mellitus? A meta-analysis. , 2010, Cardiology journal.
[19] P. O S I T I O N S T A T E M E N T,et al. Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.
[20] R. Vasan,et al. Aldosterone, C-Reactive Protein, and Plasma B-Type Natriuretic Peptide Are Associated With the Development of Metabolic Syndrome and Longitudinal Changes in Metabolic Syndrome Components , 2013, Diabetes Care.
[21] Sherita Hill Golden,et al. Race/Ethnic Difference in Diabetes and Diabetic Complications , 2013, Current Diabetes Reports.
[22] B. Falkner,et al. Aldosterone and aldosterone: renin ratio associations with insulin resistance and blood pressure in African Americans. , 2012, Journal of the American Society of Hypertension : JASH.
[23] L. Geiss,et al. Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012. , 2014, JAMA.
[24] V. Basevi. Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.
[25] A. Barnett. Type 2 diabetes and cardiovascular disease. , 2001, Nursing times.
[26] Keith C. Norris,et al. Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[27] S. Golden,et al. Type 2 diabetes and cardiovascular disease: what next? , 2014, Current opinion in endocrinology, diabetes, and obesity.
[28] Keith C. Norris,et al. African Americans, hypertension and the renin angiotensin system. , 2014, World journal of cardiology.
[29] T. Asano,et al. High-Salt Diet Enhances Insulin Signaling and Induces Insulin Resistance in Dahl Salt-Sensitive Rats , 2002, Hypertension.
[30] C. Grim,et al. Biohistory of Slavery and Blood Pressure Differences in Blacks Today A Hypothesis , 1991, Hypertension.
[31] P. Fesler,et al. Dietary Sodium, Aldosterone, and Left Ventricular Mass Changes During Long-Term Inhibition of the Renin-Angiotensin System , 2010, Hypertension.
[32] P. Dubbert,et al. Dietary assessment in African Americans: methods used in the Jackson Heart Study. , 2005, Ethnicity & disease.
[33] J. Pankow,et al. Serum potassium and the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study. , 2011, The American journal of clinical nutrition.
[34] A. Carriquiry,et al. Sodium and potassium intakes among US adults: NHANES 2003-2008. , 2012, The American journal of clinical nutrition.
[35] A. Nishiyama,et al. Biphasic Time Course of the Changes in Aldosterone Biosynthesis Under High-Salt Conditions in Dahl Salt-Sensitive Rats , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[36] Gregory Evans,et al. Laboratory, Reading Center, and Coordinating Center Data Management Methods in the Jackson Heart Study , 2004, The American journal of the medical sciences.
[37] A. Correa,et al. High-Sensitivity C-Reactive Protein Is Associated With Incident Type 2 Diabetes Among African Americans: The Jackson Heart Study , 2015, Diabetes Care.
[38] B. Adams-Huet,et al. Spironolactone Prevents Chlorthalidone-Induced Sympathetic Activation and Insulin Resistance in Hypertensive Patients , 2012, Hypertension.
[39] Sherita Hill Golden,et al. Health disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statement. , 2012, The Journal of clinical endocrinology and metabolism.
[40] D. Jacobs,et al. Correlates of urinary albumin excretion in young adult blacks and whites: the Coronary Artery Risk Development in Young Adults Study. , 2003, American journal of epidemiology.
[41] J. Tuomilehto,et al. Urinary sodium and potassium excretion and the risk of type 2 diabetes: a prospective study in Finland , 2005, Diabetologia.
[42] M. Tuck,et al. The effect of aldosterone on glucose metabolism , 2003, Current hypertension reports.
[43] L. Svetkey,et al. Heritability of salt sensitivity in black Americans. , 1996, Hypertension.
[44] P. Hopkins,et al. Aldosterone production and insulin resistance in healthy adults. , 2010, The Journal of clinical endocrinology and metabolism.